Close Menu

NEW YORK (GenomeWeb) – Cancer Genetics reported on Tuesday that its fourth quarter revenues fell 9 percent year over year, partially due to the impact on its clinical services business unit from the adoption of new revenues recognition standards at the beginning of 2018.

For the three months ended Dec. 31, 2018, the firm reported total revenues of $6.8 million, down from $7.5 million in the fourth quarter of 2017. 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The former commissioner of the FDA has returned to the venture capital firm New Enterprise Associates as a special partner on the healthcare investment team.

Astronauts have edited yeast genes on the International Space Station in an experiment designed to show how cells repair themselves in space.

Emory University has found that two of its researchers failed to divulge they had received funds from China, according to the Atlanta Journal-Constitution.

In Science this week: influence of the nuclear genome on human mitochondrial DNA, and more.